TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0

31 filings reported holding 89422GAA5 - TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0 as of Q4 2024.
TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0 has 21 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of $264,062,863 of principal .
Largest 10 bondholders include Linden Advisors LP ($62,068,000 of principal), D. E. Shaw & Co., Inc. ($41,689,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($40,692,000 of principal), Graham Capital Management, L.P. ($38,262,000 of principal), Voya Investment Management LLC ($16,500,000 of principal), Point72 Asset Management, L.P. ($14,995,000 of principal), OAKTREE CAPITAL MANAGEMENT LP ($11,500,000 of principal), SSI INVESTMENT MANAGEMENT LLC ($6,507,000 of principal), Affinity Asset Advisors, LLC ($6,000,000 of principal), and CAPSTONE INVESTMENT ADVISORS, LLC ($5,893,000 of principal).
This table shows the top 21 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.